citrulline and Muscular Weakness

citrulline has been researched along with Muscular Weakness in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (50.00)18.2507
2000's0 (0.00)29.6817
2010's1 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Caldow, MK; Chee, A; Ham, DJ; Kennedy, TL; Koopman, R; Lynch, GS1
Chrétien, D; Cormier-Daire, V; de Lonlay, P; Munnich, A; Parfait, B; Rabier, D; Rötig, A; Rustin, P; Saudubray, JM; von Kleist-Retzow, JC1

Other Studies

2 other study(ies) available for citrulline and Muscular Weakness

ArticleYear
Citrulline does not prevent skeletal muscle wasting or weakness in limb-casted mice.
    The Journal of nutrition, 2015, Volume: 145, Issue:5

    Topics: Animals; Autophagy; Biomarkers; Citrulline; Dietary Supplements; Disease Models, Animal; Fracture Fixation; Gene Expression Regulation; Hindlimb; Male; Membrane Proteins; Mice, Inbred C57BL; Microtubule-Associated Proteins; Mitochondrial Proteins; Muscle Proteins; Muscle Weakness; Muscle, Skeletal; Muscular Atrophy; Nitric Oxide Synthase Type II; Protein Isoforms; Restraint, Physical

2015
The neurogenic weakness, ataxia and retinitis pigmentosa (NARP) syndrome mtDNA mutation (T8993G) triggers muscle ATPase deficiency and hypocitrullinaemia.
    European journal of pediatrics, 1999, Volume: 158, Issue:1

    Topics: Adenosine Triphosphatases; Ataxia; Citrulline; DNA, Mitochondrial; Female; Humans; Infant; Infant, Newborn; Intestine, Small; Male; Metabolism, Inborn Errors; Muscle Weakness; Mutation; Oxidative Phosphorylation; Pedigree; Retinitis Pigmentosa; Syndrome

1999